HIV-2 is a less common strain of the human immunodeficiency virus. Like HIV-1, it targets immune cells and can result in immune system suppression over time, but it is generally linked to a slower progression of the disease. HIV-2 remains clinically significant and necessitates accurate diagnostic confirmation and ongoing medical monitoring.

HIV-2 is a form of HIV that attacks the immune system similarly to HIV-1. In many people, HIV-2 progresses at a slower pace, and the viral load in the blood may be lower compared to HIV-1, particularly in the early stages of infection. However, HIV-2 can still cause serious immune deficiency if it is not treated.
HIV-2 is transmitted through the same types of body fluids and exposure routes as HIV-1 (including sexual contact, blood exposure, and mother-to-child transmission). Overall, HIV-2 is generally considered less easily transmitted than HIV-1, but transmission can still occur.
As with HIV-1, antibodies to HIV-2 may not be detectable immediately after exposure. Testing too early can produce a negative result during the window period. If there is ongoing concern, follow-up testing at the right time is recommended.
HIV-1 और HIV-2 जैविक रूप से भिन्न हैं, और नैदानिक प्रबंधन में भी भिन्नता हो सकती है। इसलिए किसी भी सकारात्मक स्क्रीनिंग परिणाम के बाद पुष्टि करने वाली प्रयोगशाला परीक्षण महत्वपूर्ण होता है।
